We further demonstrated that a relatively selective calpain-2 inhibitor prevented calpain-2 activation, reduced neuronal damage, prevented motor and cognitive impairment, and reduced the levels of blood biomarkers reflecting brain calpain-2 activation. Here, CAPN2 is linked to Cognitive impairment.